trial

Cognitive Behavioral Therapy for Insomnia (CBT-I) in Schizophrenia(SLEEPINS)

NCTId NCT04144231
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Unknown
Enrollment 120 (estimated)
Sponsored by Helsinki University Central Hospital
Primary completion 2024-09-06
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Unknown
Enrollment
120 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
None
Start
2019-12-19
Primary completion
2024-09-06
Eligibility
ALL · 18 Years

Interventions & indications

Drugs
iCBT-IGCBT-I

Sponsors

Helsinki University Central HospitalLead Sponsor
University of HelsinkiCollaborator
Finnish Institute for Health and WelfareCollaborator
Finnish Institute of Occupational HealthCollaborator

Investigators

1
Tiina M. Paunio, M.D., Ph.D.Principal Investigator

Sites

1 total
Helsinki, Finland

Facts & assertions

4 sourced
Enrollment
120
Phase
NA
Primary Completion Date
2024-09-06
Status
UNKNOWN
relationships
The graph out of here
drug
iCBT-I
drug
GCBT-I
drug
lead_sponsor
Helsinki University Central Hospital
company
collaborator
University of Helsinki
company
Finnish Institute for Health and Welfare
company
indication
Sleep Initiation and Maintenance Disorders
indication
Schizoaffective Disorder
indication
Psychotic Disorders
indication
investigator
Tiina M. Paunio, M.D., Ph.D.
person